Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

High titers and low fucosylation of early anti-SARS-CoV-2 IgG promote hyper-inflammation by anti-inflammatory macrophages (MIL10)


ABSTRACT: Patients diagnosed with coronavirus disease 2019 (COVID-19) mostly become critically ill around the time of activation of the adaptive immune response. Here, we provide evidence that antibodies play a role in the worsening of disease at the time of seroconversion. We show that early phase severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific IgG in serum of critically ill COVID-19 patients induces hyper-inflammatory responses by human alveolar macrophages. We identified that this excessive inflammatory response is dependent on two antibody features that are specific for patients with severe COVID-19. First, inflammation is driven by high titers of anti-spike IgG, a hallmark of severe disease. Second, we found that anti-spike IgG from patients with severe COVID-19 is intrinsically more pro-inflammatory because of different glycosylation, particularly low fucosylation, of the Fc tail. Notably, low anti-spike IgG fucosylation normalized in a few weeks after initial infection with SARS-CoV-2, indicating that the increased antibody-dependent inflammation mainly occurs at the time of seroconversion. We identified Fcγ Receptor (FcγR) IIa and FcγRIII as the two primary IgG receptors that are responsible for the induction of key COVID-19-associated cytokines such as interleukin-6 and tumor necrosis factor. In addition, we show that anti-spike IgG-activated macrophages can subsequently break pulmonary endothelial barrier integrity and induce microvascular thrombosis in vitro. Finally, we demonstrate that the hyper-inflammatory response induced by anti-spike IgG can be specifically counteracted by fostamatinib, an FDA- and EMA-approved therapeutic small molecule inhibitor of the kinase, Syk.

INSTRUMENT(S): Illumina HiSeq 4000

ORGANISM(S): Homo sapiens

SUBMITTER: Hung-Jen Chen 

PROVIDER: E-MTAB-10431 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages.

Hoepel Willianne W   Chen Hung-Jen HJ   Geyer Chiara E CE   Allahverdiyeva Sona S   Manz Xue D XD   de Taeye Steven W SW   Aman Jurjan J   Mes Lynn L   Steenhuis Maurice M   Griffith Guillermo R GR   Bonta Peter I PI   Brouwer Philip J M PJM   Caniels Tom G TG   van der Straten Karlijn K   Golebski Korneliusz K   Jonkers René E RE   Larsen Mads D MD   Linty Federica F   Nouta Jan J   van Roomen Cindy P A A CPAA   van Baarle Frank E H P FEHP   van Drunen Cornelis M CM   Wolbink Gertjan G   Vlaar Alexander P J APJ   de Bree Godelieve J GJ   Sanders Rogier W RW   Willemsen Lisa L   Neele Annette E AE   van de Beek Diederik D   Rispens Theo T   Wuhrer Manfred M   Bogaard Harm Jan HJ   van Gils Marit J MJ   Vidarsson Gestur G   de Winther Menno M   den Dunnen Jeroen J  

Science translational medicine 20210511 596


Patients diagnosed with coronavirus disease 2019 (COVID-19) become critically ill primarily around the time of activation of the adaptive immune response. Here, we provide evidence that antibodies play a role in the worsening of disease at the time of seroconversion. We show that early-phase severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific immunoglobulin G (IgG) in serum of critically ill COVID-19 patients induces excessive inflammatory responses by hu  ...[more]

Similar Datasets

| EGAS00001005206 | EGA
2022-09-30 | E-MTAB-12161 | biostudies-arrayexpress
2022-02-05 | E-MTAB-10740 | biostudies-arrayexpress
2022-02-20 | GSE196938 | GEO
2021-11-29 | PXD029321 | Pride
2023-03-29 | GSE227116 | GEO
2021-03-26 | MSV000087115 | MassIVE
2021-03-25 | MSV000087099 | MassIVE
2021-03-25 | MSV000087098 | MassIVE
2022-05-19 | GSE203081 | GEO